Depo-Provera's black box: time to reconsider?

References

1. • Mosher W.D.
   • Martinez G.M.
   • Chandra A.
   • Abma J.C.
   • Willson S.J.
   Use of contraception and use of family planning services in the United States, 1982���2002. Advance data from vital and health statistics; no 350.
   National Center for Health Statistics, Hyattsville (Md)2004
   View in Article

   • Google Scholar
2. • Mishell Jr., D.R.
   • Kharma K.M.
   • Thorneycroft I.H.
   • Nakamura R.M.
   Estrogenic activity in women receiving an injectable progestogen for contraception.
   Am J Obstet Gynecol. 1972; 113: 372-376
   View in Article

   • Google Scholar
3. • Cundy T.
   • Evans M.
   • Roberts H.
   • Wattie D.
   • Ames R.
   • Reid I.R.
   Bone density in women receiving depot medroxyprogesterone acetate for contraception.
   BMJ. 1991; 208: 13-16
   View in Article

   • Google Scholar
4. • Kaunitz A.M.
   Injectable contraception ��� new and existing options.
   Obstet Gynecol Clin North Am. 2000; 27: 741-780
   View in Article

   • Google Scholar
5. • Banks E.
   • Berrington A.
   • Casabonne D.
   Overview of the relationship between use of progestogen-only contraceptives and bone mineral density.
   BJOG. 2001; 108: 1214-1221
   View in Article

   • Google Scholar
6. • Westhoff C.L.
   Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety.
   Contraception. 2003; : 6875-6887
   View in Article

   • Google Scholar
7. • Cundy T.
   • Cornish J.
   • Evans M.C.
   • Roberts H.
   • Reid I.C.
   Recovery of bone density in women who stop using medroxyprogesterone acetate.
   BMJ. 1994; 308: 247-248
   View in Article

   • Google Scholar
8. http:///www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html
   ([last accessed February 12, 2005])
   View in Article

   • Google Scholar
9. • Pettiti D.B.
   • Piaggio G.
   • Mehta S.
   • Cavioto M.C.
   • Meirik O.
   Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population: the WHO Study of Hormonal Contraception and Bone Health.
   Obstet Gynecol. 2000; 95: 736-744
   View in Article

   • Google Scholar
10. • Orr-Walker B.J.
    • Evans M.C.
    • Ames R.W.
    • Clearwater J.M.
    • Cundy T.
    • Reid I.R.
    The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Clin Endocrinol (Oxf). 1998; 49: 615-618
    View in Article

    • Google Scholar
11. • Scholes D.
    • LaCroix A.Z.
    • Ichikawa L.E.
    • Barlow W.E.
    • Ott S.M.
    Injectable hormone contraception and bone density: results from a prospective study.
    Epidemiology. 2002; 13: 581-587
    View in Article

    • Google Scholar
12. • Abma J.C.
    • Martinez G.M.
    • Mosher W.D.
    • Dawson B.S.
    Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2002. National Center for Health Statistics.
    Vital Health Stat. 2004; 23 ([last accessed 5/26/05]): 1-48
    http://www.cdc.gov/nchs/data/series/sr_23/sr23_024.pdf
    View in Article

    • Google Scholar
13. • Scholes D.
    • LaCroix A.Z.
    • Ichikawa L.E.
    • Barlow W.E.
    • Ott S.M.
    Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Arch Pediatr Adolesc Med. 2005; 159: 139-144
    View in Article

    • Google Scholar
14. • Cundy T.
    • Ames R.
    • Horne A.
    • et al.
    A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
    J Clin Endocrinol Metab. 2003; 88: 78-81
    View in Article

    • Google Scholar
15. • Kaunitz A.M.
    • Garceau R.J.
    • Cromie M.A.
    • the Lunelle Study Group
    Comparative safety, efficacy, and cycle control of Lunelle��� monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum�� 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic).
    Contraception. 1999; : 60179-60187
    View in Article

    • Google Scholar
16. • Cromer B.A.
    • Lazebnik R.
    • Rome E.
    • et al.
    Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception.
    Am J Obstet Gynecol. 2005; 192: 42-47
    View in Article

    • Google Scholar
17. • Kaunitz A.M.
    Long-acting hormonal contraception: assessing impact on bone-density, weight, and mood.
    Int J Fertil. 1999; 44: 110-117
    View in Article

    • Google Scholar
18. • Kalkwarf H.J.
    • Specker B.L.
    • Bianchi D.C.
    • Ranz J.
    • Ho M.
    Bone mineral loss during lactation and recovery after weaning.
    N Engl J Med. 1997; 337: 523-528
    View in Article

    • Google Scholar
19. • Polatti F.
    • Capuzzo E.
    • Viazzo F.
    • Colleoni R.
    • Lersy C.
    Bone mineral changes during and after lactation.
    Obstet Gynecol. 1999; 94: 52-56
    View in Article

    • Google Scholar
20. • Sowers M.F.
    • Corton G.
    • Shapiro B.
    • et al.
    Changes in bone density with lactation.
    JAMA. 1993; 269: 3130-3135
    View in Article

    • Google Scholar
21. • Michaelsson K.
    • Baron J.A.
    • Farahmand L.
    Influence of parity and lactation on hip fracture risk.
    Am J Epidemiol. 2001; 153: 1166-1172
    View in Article

    • Google Scholar
22. • Chantry C.J.
    • Auinger P.
    • Byrd R.S.
    Lactation among adolescent mothers and subsequent bone mineral density.
    Arch Pediatr Adolesc Med. 2004; 158: 650-656
    View in Article

    • Google Scholar
23. • Grimes D.A.
    • Schultz K.
    Surrogate end points in clinical research: hazardous to your health.
    Obstet Gynecol. 2005; 105: 1114-1118
    View in Article

    • Google Scholar
24. • Centers for Disease Control
    Achievements in public health, 1990���1999: family planning.
    MMWR Morb Mortal Wkly Rep. 1999; 48: 1073-1080
    View in Article

    • Google Scholar